Items where authors include "Barton, G"

Article

Holland, R, Bond, C, Alldred, D orcid.org/0000-0002-2525-4854 et al. (25 more authors) (2023) Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trial. British Medical Journal (BMJ), 380. e071883. ISSN 1759-2151

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Wailoo, A, Alava, MH, Pudney, S et al. (6 more authors) (2021) An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis. Value in Health, 24 (4). pp. 568-574. ISSN 1098-3015

Bond, CM, Holland, R, Alldred, DP orcid.org/0000-0002-2525-4854 et al. (17 more authors) (2020) Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials, 21 (1). 439. 439-. ISSN 1745-6215

Bond, CM, Holland, R, Alldred, DP orcid.org/0000-0002-2525-4854 et al. (18 more authors) (2020) Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study. Trials, 21 (103). ISSN 1745-6215

Hernandez Alava, MH, Wailoo, A, Grimm, S et al. (7 more authors) (2018) EQ-5D-5L versus EQ-5D-3L: The Impact on Cost-Effectiveness in the United Kingdom. Value in Health, 21 (1). pp. 49-56. ISSN 1098-3015

Millar, AN, Daffu-O'Reilly, A orcid.org/0000-0002-3022-4596, Hughes, C et al. (8 more authors) (2017) Development of a Core Outcome Set for effectiveness trials aimed at optimising prescribing in older adults in care homes. Trials, 18. 175. ISSN 1745-6215

Proceedings Paper

Millar, A, Hughes, C, Alldred, DP orcid.org/0000-0002-2525-4854 et al. (15 more authors) (2016) Development of a core outcome set (COS) for studies relating to prescribing in care homes: the care homes independent pharmacist prescribing study (CHIPPS). In: International Journal of Pharmacy Practice. Royal Pharmaceutical Society, 04-05 Sep 2016, Birmingham, UK. Wiley , p. 17.